Literature DB >> 24648974

Serum microRNAs: A new diagnostic method for colorectal cancer.

Yi Yang1, Xiaodong Gu1, Minwei Zhou1, Jianbin Xiang1, Zongyou Chen1.   

Abstract

Colorectal cancer (CRC) is the third most common malignant tumor worldwide, affecting over 1.23 million individuals annually. Over the past several years, the role of microRNAs (miRNAs) in CRC cells have been extensively investigated. Recently, it was discovered that extracellular miRNAs circulate in the blood of healthy individuals as well as CRC patients. Serum circulating miRNAs as novel biomarkers may be a new approach to CRC diagnosis. However, their secretory mechanism and biological function have not been fully elucidated. In this review, the main serum miRNAs used as potential diagnostic biomarkers for CRC, such as miR-92, miR-141, miR-29a, miR-21, miR-221, miR-601 and miR-760, were summarized. In addition, the mechanism of miRNA secretion from CRC cells was discussed. It is recommended that additional studies focus on the usefulness of serum miRNAs for early CRC diagnosis, prognosis and therapeutics.

Entities:  

Keywords:  colorectal cancer; diagnosis; microRNA

Year:  2013        PMID： 24648974      PMCID： PMC3917018          DOI： 10.3892/br.2013.109

Source DB:  PubMed          Journal:  Biomed Rep        ISSN： 2049-9434


  40 in total

Review 1.  Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis.

Authors:  Nobuyoshi Kosaka; Haruhisa Iguchi; Takahiro Ochiya
Journal:  Cancer Sci       Date:  2010-07-07       Impact factor: 6.716

2.  Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming.

Authors:  J Wolfers; A Lozier; G Raposo; A Regnault; C Théry; C Masurier; C Flament; S Pouzieux; F Faure; T Tursz; E Angevin; S Amigorena; L Zitvogel
Journal:  Nat Med       Date:  2001-03       Impact factor: 53.440

3.  Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection.

Authors:  Alma Zernecke; Kiril Bidzhekov; Heidi Noels; Erdenechimeg Shagdarsuren; Lin Gan; Bernd Denecke; Mihail Hristov; Thomas Köppel; Maliheh Nazari Jahantigh; Esther Lutgens; Shusheng Wang; Eric N Olson; Andreas Schober; Christian Weber
Journal:  Sci Signal       Date:  2009-12-08       Impact factor: 8.192

4.  Circulating miR-221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression.

Authors:  Xing-xiang Pu; Guo-liang Huang; Hong-qiang Guo; Cheng-cheng Guo; Haoran Li; Shen Ye; Suxia Ling; Li Jiang; Ying Tian; Tong-yu Lin
Journal:  J Gastroenterol Hepatol       Date:  2010-10       Impact factor: 4.029

5.  MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma.

Authors:  Aaron J Schetter; Suet Yi Leung; Jane J Sohn; Krista A Zanetti; Elise D Bowman; Nozomu Yanaihara; Siu Tsan Yuen; Tsun Leung Chan; Dora L W Kwong; Gordon K H Au; Chang-Gong Liu; George A Calin; Carlo M Croce; Curtis C Harris
Journal:  JAMA       Date:  2008-01-30       Impact factor: 56.272

Review 6.  MiRNAs and cancer.

Authors:  Rosa Visone; Carlo M Croce
Journal:  Am J Pathol       Date:  2009-03-05       Impact factor: 4.307

7.  Community compliance with carcinoembryonic antigen: follow-up of patients with colorectal cancer.

Authors:  Jennifer L Spratlin; David Hui; John Hanson; Charles Butts; Heather-Jane Au
Journal:  Clin Colorectal Cancer       Date:  2008-03       Impact factor: 4.481

8.  Cancer statistics, 2009.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2009-05-27       Impact factor: 508.702

Review 9.  Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use.

Authors:  M J Duffy; A van Dalen; C Haglund; L Hansson; E Holinski-Feder; R Klapdor; R Lamerz; P Peltomaki; C Sturgeon; O Topolcan
Journal:  Eur J Cancer       Date:  2007-05-18       Impact factor: 9.162

Review 10.  MicroRNA: implications for cancer.

Authors:  Stefanie Sassen; Eric A Miska; Carlos Caldas
Journal:  Virchows Arch       Date:  2007-11-27       Impact factor: 4.064
View more
  18 in total

1.  Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma.

Authors:  Lin Chen; Feihu Chu; Yali Cao; Jianguo Shao; Feng Wang
Journal:  Tumour Biol       Date:  2015-04-24

2.  miR-99a directly targets the mTOR signalling pathway in breast cancer side population cells.

Authors:  Z Yang; Y Han; K Cheng; G Zhang; X Wang
Journal:  Cell Prolif       Date:  2014-10-27       Impact factor: 6.831

3.  miR-503 inhibits cell proliferation and induces apoptosis in colorectal cancer cells by targeting E2F3.

Authors:  Shun-Wu Chang; Jie Yue; Bao-Chun Wang; Xue-Li Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

4.  Cell-autonomous and cell non-autonomous downregulation of tumor suppressor DAB2IP by microRNA-149-3p promotes aggressiveness of cancer cells.

Authors:  Arianna Bellazzo; Giulio Di Minin; Elena Valentino; Daria Sicari; Denis Torre; Luigi Marchionni; Federica Serpi; Michael B Stadler; Daniela Taverna; Gaia Zuccolotto; Isabella Monia Montagner; Antonio Rosato; Federica Tonon; Cristina Zennaro; Chiara Agostinis; Roberta Bulla; Miguel Mano; Giannino Del Sal; Licio Collavin
Journal:  Cell Death Differ       Date:  2018-03-22       Impact factor: 15.828

5.  Effects of preanalytic variables on circulating microRNAs in whole blood.

Authors:  Hua Zhao; Jie Shen; Qiang Hu; Warren Davis; Leonardo Medico; Dan Wang; Li Yan; Yuqing Guo; Biao Liu; Maochun Qin; Mary Nesline; Qianqian Zhu; Song Yao; Christine B Ambrosone; Song Liu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-12       Impact factor: 4.254

Review 6.  Survival Benefit and Safety of Bevacizumab in Combination with Erlotinib as Maintenance Therapy in Patients with Metastatic Colorectal Cancer: A Meta-Analysis.

Authors:  Wei Xu; Yang Gong; Meng Kuang; Peng Wu; Chunxiang Cao; Jinfei Chen; Cuiju Tang
Journal:  Clin Drug Investig       Date:  2017-02       Impact factor: 2.859

7.  Combined detection of serum exosomal miR-21 and HOTAIR as diagnostic and prognostic biomarkers for laryngeal squamous cell carcinoma.

Authors:  Jingting Wang; Yandong Zhou; Jianguang Lu; Yanan Sun; Hui Xiao; Ming Liu; Linli Tian
Journal:  Med Oncol       Date:  2014-08-07       Impact factor: 3.064

Review 8.  Regulatory role of small nucleolar RNAs in human diseases.

Authors:  Grigory A Stepanov; Julia A Filippova; Andrey B Komissarov; Elena V Kuligina; Vladimir A Richter; Dmitry V Semenov
Journal:  Biomed Res Int       Date:  2015-04-28       Impact factor: 3.411

9.  Folic acid supplements and colorectal cancer risk: meta-analysis of randomized controlled trials.

Authors:  Tingting Qin; Mulong Du; Haina Du; Yongqian Shu; Meilin Wang; Lingjun Zhu
Journal:  Sci Rep       Date:  2015-07-01       Impact factor: 4.379

10.  Serum microRNA 143 and microRNA 215 as potential biomarkers for the diagnosis of chronic hepatitis and hepatocellular carcinoma.

Authors:  Zhu-qing Zhang; Hua Meng; Nan Wang; Li-na Liang; Li-na Liu; Shu-ming Lu; Yong Luan
Journal:  Diagn Pathol       Date:  2014-07-02       Impact factor: 2.644
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.